当前位置:首页 - 行情中心 - 富森美(002818) - 财务分析 - 利润表

富森美

(002818)

  

流通市值:33.95亿  总市值:85.17亿
流通股本:2.98亿   总股本:7.48亿

利润表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、营业总收入924,192,679.18648,800,315.8329,927,635.021,429,881,171.12
  营业收入924,192,679.18648,800,315.8329,927,635.021,429,881,171.12
二、营业总成本429,954,529.22283,817,709.24136,764,157.05633,434,005.68
  营业成本320,172,367.91207,968,052.7899,009,108.32468,387,297.07
  税金及附加63,403,951.144,178,767.9222,622,983.0195,685,248.32
  销售费用4,277,522.592,793,204.681,205,372.375,193,788.39
  管理费用42,216,811.6929,131,159.6314,105,736.364,944,349.2
  财务费用-116,124.07-253,475.77-179,042.95-776,677.3
  其中:利息费用399,404.06273,294.45135,550571,475.21
  其中:利息收入1,086,423.08903,445.02412,547.622,480,039.46
三、其他经营收益
  加:公允价值变动收益29,165,127.07-19,658,212.37-31,664,840.82-14,581,127.87
  加:投资收益45,139,248.4540,040,629.0620,007,194.3462,646,854.73
  资产处置收益-685.83-685.83--
  资产减值损失(新)-1,189,508.17-1,321,882.32-1,290,136.48-2,653,962.16
  信用减值损失(新)-474,433.5-2,433,312.92-4,429,316.96-1,259,423.42
  其他收益1,168,125.57734,943.31493,373.821,198,746.89
四、营业利润568,046,023.55382,344,085.49176,279,751.87841,798,253.61
  加:营业外收入1,135,273.27531,303.82173,705.152,473,878.62
  减:营业外支出168,424.6663,843.2962,751.236,910,992.47
五、利润总额569,012,872.16382,811,546.02176,390,705.79837,361,139.76
  减:所得税费用81,747,159.9352,823,546.6823,471,203.35134,754,076.56
六、净利润487,265,712.23329,987,999.34152,919,502.44702,607,063.2
(一)按经营持续性分类
  持续经营净利润487,265,712.23329,987,999.34152,919,502.44702,607,063.2
(二)按所有权归属分类
  归属于母公司股东的净利润477,302,662.93318,240,499.8147,863,965.75690,257,240.79
  少数股东损益9,963,049.311,747,499.545,055,536.6912,349,822.41
  扣除非经常损益后的净利润437,624,692.18326,677,705.73170,740,330.86681,709,696.12
七、每股收益
  (一)基本每股收益0.640.430.20.92
  (二)稀释每股收益0.640.430.20.92
九、综合收益总额487,265,712.23329,987,999.34152,919,502.44702,607,063.2
  归属于母公司股东的综合收益总额477,302,662.93318,240,499.8147,863,965.75690,257,240.79
  归属于少数股东的综合收益总额9,963,049.311,747,499.545,055,536.6912,349,822.41
公告日期2025-10-282025-08-282025-04-292025-02-28
审计意见(境内)标准无保留意见
TOP↑